Posted: Monday, August 30, 2021. 4:40 pm CST.
By Rubén Morales Iglesias: Pfizer and BioNTech have reached an agreement with a Brazilian biopharmaceutical company to mass-produce it COVID-19 vaccine, now officially known as Comirnaty, for Latin American countries, though that won’t be until 2022, according to the Miami Herald.
The deal with Eurofarma Laboratórios SA is expected to produce over 100 million doses annually for Latin American countries that have and will have bilateral agreements with Pfizer countries.
Pfizer and BioNTech already have bilateral agreements with 13 Latin American countries, namely Argentina, Brazil, Chile, Colombia, Costa Rica, Ecuador, El Salvador, Honduras, Mexico, Panama, Paraguay, Peru, and Uruguay.
The transfer of the technology and expertise, and the installation of equipment to Eurofarma’s facility in São Paulo, Brazil is expected to begin right away, but actual manufacturing of finished doses will not start until 2022 said Pfizer in a press release.
According to Bloomberg, the vaccine will be produced in the United States, sent to Eurofarma in Brazil, which will carry out the so-called fill-and-finish process of placing the vaccine into sterile vials. The vaccines will then be distributed to Latin American countries.
Carlos Murillo, Pfizer’s Latin America president, said Pfizer’s partnership with Eurofarma forms part of Pfizer’s objective of better supporting the global need for vaccines.
Murillo said that while the financial terms remain confidential, high and middle-income countries will pay a higher price than low-income countries.
“Low and lower-middle-income countries will pay a not-for-profit price,” Murilo said.
Аdvеrtіѕе wіth thе most visited news site in Веlіzе ~ Wе оffеr fullу сuѕtоmіzаblе аnd flехіblе dіgіtаl mаrkеtіng расkаgеѕ. Yоur соntеnt іѕ dеlіvеrеd іnѕtаntlу tо thоuѕаndѕ оf uѕеrѕ іn Веlіzе аnd аbrоаd! Соntасt uѕ аt [email protected] оr саll uѕ аt 501-601-0315.
© 2021, BreakingBelizeNews.com. This article is the copyrighted property of Breaking Belize News. Written permission must be obtained before reprint in online or print media. REPRINTING CONTENT WITHOUT PERMISSION AND/OR PAYMENT IS THEFT AND PUNISHABLE BY LAW.